Download this PDF file
Crossref Citations
1. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT)
GR Özalp, B Zik, A Bastan, S Peker, ES Özdemir-Salcı, I Bastan, I Darbaz, S Salar, K Karakas
Biotechnic & Histochemistry vol: 87 issue: 5 first page: 325 year: 2012
doi: 10.3109/10520295.2012.655311
2. Cancer immunotherapy in veterinary medicine: Current options and new developments
Daniel Regan, Amanda Guth, Jonathan Coy, Steven Dow
The Veterinary Journal vol: 207 first page: 20 year: 2016
doi: 10.1016/j.tvjl.2015.10.008
3. Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment
Petra Kucerova, Monika Cervinkova
Anti-Cancer Drugs vol: 27 issue: 4 first page: 269 year: 2016
doi: 10.1097/CAD.0000000000000337
4. Utilizing Microbes to Treat Naturally Occurring Cancer in Veterinary Species
Sita S. Withers, Ellen E. Sparger, Bonnie Boudreaux, Nicola J. Mason
Current Clinical Microbiology Reports vol: 6 issue: 4 first page: 200 year: 2019
doi: 10.1007/s40588-019-00130-7
5. Factor Analysis for Bicluster Acquisition (FABIA) revealed vincristine-sensitive transcript pattern of canine transmissible venereal tumors
K. Chokeshaiusaha, D. Puthier, C. Nguyen, P. Sudjaidee, T. Sananmuang
Heliyon vol: 5 issue: 5 first page: e01558 year: 2019
doi: 10.1016/j.heliyon.2019.e01558
6. Canine transmissible venereal tumour: a review
B. Ganguly, U. Das, A. K. Das
Veterinary and Comparative Oncology vol: 14 issue: 1 first page: 1 year: 2016
doi: 10.1111/vco.12060
7. Canine Transmissible Venereal Tumor: Etiopathology, Transmission and Treatment
Urfeya Mirza, Uiase Bin Farooq, Dil Mohammad M
Asian Journal of Animal and Veterinary Advances vol: 17 issue: 2 first page: 39 year: 2022
doi: 10.3923/ajava.2022.39.43
8. Intratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour
Halit Kanca, Gizem Tez, Kazim Bal, Dogukan Ozen, Eray Alcigir, Sevil Atalay Vural
Veterinary Medicine and Science vol: 4 issue: 4 first page: 364 year: 2018
doi: 10.1002/vms3.119
9. Repurposing Infectious Diseases Vaccines Against Cancer
Liese Vandeborne, Pan Pantziarka, An M. T. Van Nuffel, Gauthier Bouche
Frontiers in Oncology vol: 11 year: 2021
doi: 10.3389/fonc.2021.688755
10. Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients
Christopher J. Pinard, Ashley A. Stegelmeier, Byram W. Bridle, Anthony J. Mutsaers, R. Darren Wood, Geoffrey A. Wood, J. Paul Woods, Samuel E. Hocker
Veterinary and Comparative Oncology vol: 20 issue: 2 first page: 427 year: 2022
doi: 10.1111/vco.12788
11. Vincristine in Cancer Therapy: Mechanisms, Efficacy, and Future Perspectives
Nitika Garg, Joviana Farhat, Sanchit Dhankhar, Samrat Chauhan, Rajni Bala, Reecha Madaan, Himanshu Sharma, Monika Saini, Thakur Gurjeet Singh, Afaf Ahmed Aldahish, Zainab M. Almarhoon, Basem Al-Omari, Javad Sharifi-Rad
Current Medicinal Chemistry vol: 32 issue: 32 first page: 6941 year: 2025
doi: 10.2174/0109298673319496240911060138
12. Clinical Guidelines for Canine Transmissible Venereal Tumour Treatment: Systematic Review and Meta‐Analysis
Pedro Antônio Bronhara Pimentel, Antonio Giuliano, Petros Odatzoglou, Natalia Ignatenko, Raphael Rocha Wenceslau, Isabella Oliveira Almeida, Paloma Helena Sanches da Silva, Mariana de Pádua Costa, Rodrigo dos Santos Horta
Veterinary and Comparative Oncology vol: 23 issue: 2 first page: 125 year: 2025
doi: 10.1111/vco.13038
13. Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs
Rachel V. Brady, Douglas H. Thamm
Frontiers in Immunology vol: 14 year: 2023
doi: 10.3389/fimmu.2023.1176807
14. Developing T Cell Cancer Immunotherapy in the Dog with Lymphoma
C. M. O'Connor, H. Wilson-Robles
ILAR Journal vol: 55 issue: 1 first page: 169 year: 2014
doi: 10.1093/ilar/ilu020
